Css LLC Eli Lilly & CO Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $32,155 - $37,467	-100 Reduced 3.23%	3,000 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $919,088 - $1.05 Million	3,100 New	3,100 $1 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.97 Million - $2.43 Million	-8,900 Reduced 81.65%	2,000 $462,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $1.97 Million - $2.55 Million	10,900 New	10,900 $2.5 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $14,523 - $15,797	-136 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $7.37 Million - $8.61 Million	-66,566 Reduced 99.8%	136 $15,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $7.42 Million - $8.74 Million	66,702 New	66,702 $8.66 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.